- Investing.com
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated platform for health plan administration and value-based business infrastructure. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management; and Machinify Auth, a software platform that leverages advances in artificial intelligence. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Value-Based Care | Evolent Health navigates challenges in the value-based care market, focusing on improving patient outcomes while managing costs in a competitive landscape |
Financial Hurdles | Explore Evolent's efforts to overcome elevated oncology costs and operational challenges, with strategies to boost profitability and stabilize performance |
Strategic Realignment | Delve into Evolent's contract renegotiations and rate adjustments, securing $100-$105 million in annual increases to mitigate rising healthcare costs |
Future Prospects | Analysts project a $13-$20 price target range, with Evolent aiming for 15%+ revenue growth and 20% adjusted EBITDA growth off the 2025 base |
Metrics to compare | EVH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEVHPeersSector | |
---|---|---|---|---|
P/E Ratio | −6.0x | −0.9x | −0.6x | |
PEG Ratio | 0.08 | −0.02 | 0.00 | |
Price/Book | 1.2x | 1.3x | 2.6x | |
Price / LTM Sales | 0.5x | 1.1x | 3.3x | |
Upside (Analyst Target) | 61.8% | 28.1% | 38.7% | |
Fair Value Upside | Unlock | 28.8% | 5.1% | Unlock |